eli lilly retatrutide phase 3 trial Shows 28% Weight Loss in 80 Weeks Retatrutide Phase 3: TRIUMPH Program
Description
In clinical studies , exenatide led to about 10 lbs of weight loss over 1224 weeks in adults without diabetes
Both medications are dosed weekly, but semaglutide maintains higher residual levels at the end of each dosing interval relative to its peak
The body has protective mechanisms against large energy deficits that make outrunning a plateau nearly impossible through exercise alone
10.1038/nm1196-1254 58 ShanY.GaoX.ZhaoK.XuC.LiH.HuY.et al (2023)
Lau T, Schild S, Klos B, Schraml J, Archid R, Stengel A, et al
Methods We searched PubMed for studies published before March 2025
